The antioxidative property of melatonin against brain ischemia

Expert Rev Neurother. 2016 Jul;16(7):841-8. doi: 10.1080/14737175.2016.1182020. Epub 2016 May 9.

Abstract

Introduction: This review briefly summarizes some of the large amount of data documenting the ability of melatonin to limit molecular and organ tissue damage in neural ischemia-reperfusion injury (stroke), where free radicals are generally considered as being responsible for much of the resulting tissue destruction.

Area covered: Melatonin actions that have been identified include its ability to directly neutralize a number of toxic reactants and stimulate antioxidative enzymes. Furthermore, several of its metabolites such as N(1)-acetyl-N(2)-formyl-5- methoxykynuramine (AFMK) and N(1)-acetyl-5-methoxykynuramine (AMF), are themselves scavengers suggesting that there is a cascade of reactions that greatly increase the efficacy of melatonin. Expert Commentary: However, the mechanisms by which melatonin is protective in such widely diverse areas of the cell and different organs are likely not yet all identified.

Keywords: Melatonin; antioxidant; free radicals; ischemia-reperfusion injury; oxidative stress.

Publication types

  • Review

MeSH terms

  • Antioxidants*
  • Brain Ischemia*
  • Free Radicals
  • Humans
  • Kynuramine / analogs & derivatives
  • Melatonin*

Substances

  • Antioxidants
  • Free Radicals
  • Kynuramine
  • N-acetyl-5-methoxy kynurenamine
  • Melatonin